Kuru Bekir, Camlibel Mithat, Dinc Soykan, Gulcelik Mehmet A, Alagol Haluk
Department of General Surgery, Ankara Oncology Education and Research Hospital, Ankara, Turkey.
World J Surg. 2004 Mar;28(3):236-41. doi: 10.1007/s00268-003-7215-1. Epub 2004 Feb 17.
Postmastectomy irradiation substantially reduces the risk of locoregional recurrences (LRR) of breast carcinoma. However, debates continue on the prognostic factors for radiotherapy and the effect of radiotherapy on overall survival. The present study was undertaken to investigate the prognostic significance of level III positive nodes, along with the other factors for LRR, and to evaluate the effect of postmastectomy radiotherapy on overall survival among node-positive breast carcinoma treated systemically. Data from 549 consecutive node-positive breast cancer patients who underwent modified radical mastectomy and received adjuvant systemic therapy were studied retrospectively. Prognostic factors for LRR and the effect of postmastectomy radiotherapy on overall survival were analyzed. Survival curves were generated by the Kaplan-Meier method, and multivariate analysis was performed by the Cox proportional hazard model. The 5-year locoregional recurrence rate is 7%. Apical invasion was found to be an independent prognostic factor for LRR (HR 2.6, CI 1.29-5.35) along with a finding of 4 or more positive nodes and T3 tumor. Adjuvant radiotherapy decreased LRR and improved survival significantly. Apical invasion, 4 or more positive axillary lymph nodes, and T3 tumor are the predictors of LRR, and patients with these adverse factors are candidates for adjuvant radiotherapy. Postmastectomy radiotherapy improves overall survival.
乳房切除术后放疗可显著降低乳腺癌局部区域复发(LRR)的风险。然而,关于放疗的预后因素以及放疗对总生存期的影响仍存在争议。本研究旨在探讨Ⅲ级阳性淋巴结的预后意义以及其他LRR相关因素,并评估乳房切除术后放疗对接受全身治疗的淋巴结阳性乳腺癌患者总生存期的影响。对549例连续接受改良根治性乳房切除术并接受辅助全身治疗的淋巴结阳性乳腺癌患者的数据进行回顾性研究。分析LRR的预后因素以及乳房切除术后放疗对总生存期的影响。采用Kaplan-Meier法生成生存曲线,并通过Cox比例风险模型进行多因素分析。5年局部区域复发率为7%。发现顶端侵犯是LRR的独立预后因素(风险比2.6,可信区间1.29 - 5.35),同时伴有4个或更多阳性淋巴结以及T3期肿瘤。辅助放疗可显著降低LRR并提高生存率。顶端侵犯、4个或更多腋窝阳性淋巴结以及T3期肿瘤是LRR的预测因素,具有这些不良因素的患者是辅助放疗的候选对象。乳房切除术后放疗可提高总生存期。